The Substance Abuse and Mental Health Services Administration (SAMHSA) has released guidance clarifying rules around prescribing buprenorphine and methadone in opioid treatment programs and office-based opioid treatment settings. This new guidance permits DATA 2000 waivered prescribers to evaluate patients by telehealth (including telephone consultation) prior to the first prescription. Please see the SAMHSA website for additional […]